These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38518294)

  • 1. Patterns of recurrence and disease progression in patients with positive-margin olfactory neuroblastoma following primary resection.
    Bauman MMJ; Graves JP; Haller TJ; McMillan RA; Routman DM; Raghunathan A; Stokken JK; Link MJ; Moore EJ; Choby G; Van Gompel JJ
    J Neurosurg; 2024 Sep; 141(3):711-719. PubMed ID: 38518294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade.
    Choby G; Geltzeiler M; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; McMillan R; Nayak J; O'Byrne J; Patel C; Patel Z; Peris Celda M; Pinheiro-Neto C; Sanusi O; Snyderman C; Thorp BD; Van Gompel JJ; Young SC; Zenonos G; Zwagerman NT; Wang EW
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):837-844. PubMed ID: 37535372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Analysis and Prognostic Factors After Endonasal Resection of Advanced Olfactory Neuroblastomas: A Single Institution Experience.
    Song X; Yang J; Yuan C; Gu D; Wang L; Zhang Q; Zhou C; Wang H; Hu L; Zhang C; Liu Q; Wang D; Sun X; Yu H
    J Otolaryngol Head Neck Surg; 2024; 53():19160216241267737. PubMed ID: 39164943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb.
    Mays AC; Bell D; Ferrarotto R; Phan J; Roberts D; Fuller CD; Frank SJ; Raza SM; Kupferman ME; DeMonte F; Hanna EY; Su SY
    Laryngoscope; 2018 Jun; 128(6):1274-1280. PubMed ID: 29226334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival outcomes and recurrence patterns of olfactory neuroblastoma: A 13-year experience at a single institution.
    Kikuchi M; Nakagawa T; Kitada Y; Matsunaga M; Tanji M; Hiraoka S; Nakashima R; Nakajima A; Yoshimura M; Omori K
    Auris Nasus Larynx; 2023 Aug; 50(4):550-557. PubMed ID: 36588056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence morbidity of olfactory neuroblastoma.
    Melder K; Mace JC; Choby G; Almeida JP; Champagne PO; Chan E; Ciporen J; Chaskes MB; Fernandez-Miranda J; Fung NK; Gardner P; Hwang P; Ji KSY; Kalyvas A; Kong KA; Patel C; Patel Z; Celda MP; Pinheiro-Neto CD; Snyderman C; Thorp BD; Van Gompel JJ; Zenonos G; Zwagerman NT; Sanusi O; Wang EW; Geltzeiler M
    Int Forum Allergy Rhinol; 2024 Sep; 14(9):1435-1445. PubMed ID: 38567900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and outcome in 12 cases of olfactory neuroblastoma at Mexico´s National Cancer Institute: A retrospective clinical analysis and literature review.
    Navarro-Fernández JO; Serrato-Avila JL; Hernández-Varela M; Tejada-Pineda MF; Hernández-Reséndiz RE; Monroy-Sosa A; Cacho-Díaz B; Herrera-Gómez Á; Reyes-Soto G
    Cir Cir; 2020; 88(4):453-460. PubMed ID: 32567594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Kadish and Modified Dulguerov Staging Systems for Olfactory Neuroblastoma: An Individual Participant Data Meta-analysis.
    Arnold MA; Farnoosh S; Gore MR
    Otolaryngol Head Neck Surg; 2020 Sep; 163(3):418-427. PubMed ID: 32286935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and Quality-of-Life Measures after Endoscopic Endonasal Resection of Kadish Stage C Olfactory Neuroblastomas.
    Sun Y; Huang Q; Cui S; Wang M; Zhang N; Zhang S; Yang B; Qiu E; Huang Z; Zhou B
    World Neurosurg; 2021 Jul; 151():e58-e67. PubMed ID: 33798777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients.
    McMillan RA; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Stokken JK; Van Abel KM; O'Byrne J; Giannini C; Chintakuntlawar A; Pinheiro Neto CD; Peris Celda M; Foote R; Choby G
    Int Forum Allergy Rhinol; 2022 Dec; 12(12):1457-1467. PubMed ID: 35385606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
    Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
    Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.
    Harvey RJ; Nalavenkata S; Sacks R; Adappa ND; Palmer JN; Purkey MT; Schlosser RJ; Snyderman C; Wang EW; Woodworth BA; Smee R; Havas T; Gallagher R
    Head Neck; 2017 Dec; 39(12):2425-2432. PubMed ID: 28945299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of multidisciplinary approaches on the outcomes of olfactory neuroblastoma treated with postoperative radiotherapy.
    Tsutsumi Y; Omura K; Kijima Y; Kobayashi M; Fukasawa N; Takeda T; Ebihara T; Aoki S; Otori N; Kojima H; Aoki M
    Cancer Med; 2024 Mar; 13(5):e6943. PubMed ID: 38497548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Open and Endoscopic Approaches in the Resection of Esthesioneuroblastoma.
    Barinsky GL; Azmy MC; Kilic S; Grube JG; Baredes S; Hsueh WD; Eloy JA
    Ann Otol Rhinol Laryngol; 2021 Feb; 130(2):136-141. PubMed ID: 32627574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failures after surgical resection in olfactory neuroblastoma.
    Kim N; Lee CG; Kim EH; Kim CH; Keum KC; Lee KS; Chang JH; Suh CO
    J Neurooncol; 2019 Jan; 141(2):459-466. PubMed ID: 30506150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic Endonasal Management of Olfactory Neuroblastoma: A Retrospective Analysis of 10 Patients with Quality-of-Life Measures.
    Manthuruthil C; Lewis J; McLean C; Batra PS; Barnett SL
    World Neurosurg; 2016 Jun; 90():1-5. PubMed ID: 26899467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark.
    Gram SB; Grønhøj C; Mann H; Jakobsen KK; Kiss K; Bilde A; von Buchwald C
    APMIS; 2018 Aug; 126(8):663-666. PubMed ID: 30168622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esthesioneuroblastoma: irradiation alone and surgery alone are not enough.
    Gruber G; Laedrach K; Baumert B; Caversaccio M; Raveh J; Greiner R
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):486-91. PubMed ID: 12243826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory neuroblastoma: a single-center experience.
    König M; Osnes T; Jebsen P; Evensen JF; Meling TR
    Neurosurg Rev; 2018 Jan; 41(1):323-331. PubMed ID: 28540633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory neuroblastoma: 14-year experience at an Australian tertiary centre and the role for longer-term surveillance.
    Schmidt C; Potter N; Porceddu S; Panizza B
    J Laryngol Otol; 2017 Jul; 131(S2):S29-S34. PubMed ID: 27917732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.